Literature DB >> 4083538

Morphogenesis of human cardiac outflow.

R P Thompson, H Sumida, V Abercrombie, Y Satow, T P Fitzharris, N Okamoto.   

Abstract

The developmental anatomy of human cardiac outflow was studied in a series of 16 normal embryos (gestational days 29-39, crown-rump length 6-20 mm, stages 14-19). Structural features and kinetics during truncal septation (TS) were described from external photographs, serial histological sections, and computer graphic reconstructions of selected tissues. Early in the period studied, the tubular myocardium ensheathed the single cardiac lumen and spiralling conotruncal ridges, which were filled with mesenchymal cells during days 31-33. As TS began (late stage 16), the aorticopulmonary (AP) septum appeared across the dorsal wall of the aortic sac between arches IV and VI. Mesenchymal condensations formed within the AP septum, crossing the lumen bifurcation to extend along the truncal ridges to the myocardium. During days 35-37, the cephalic margin of the myocardium grew or folded in toward these mesenchymal condensations between the developing valves and within the nearby conal ridges, which appeared to fuse to separate the subvalvular outflow channels by day 39. These observations are consistent with studies in chicks and rats which suggest that mesenchymal condensations or cell death foci interact with the distal myocardial rim during TS to form a structural septation complex dividing the two arterial streams.

Entities:  

Mesh:

Year:  1985        PMID: 4083538     DOI: 10.1002/ar.1092130414

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  12 in total

Review 1.  Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks.

Authors:  Robert H Anderson; Sandra Webb; Nigel A Brown; Wouter Lamers; Antoon Moorman
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 2.  Cardiovascular embryology.

Authors:  R Abdulla; G A Blew; M J Holterman
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

3.  Phylogeny informs ontogeny: a proposed common theme in the arterial pole of the vertebrate heart.

Authors:  Adrian C Grimes; Ana Carmen Durán; Valentín Sans-Coma; Danyal Hami; Massimo M Santoro; Miguel Torres
Journal:  Evol Dev       Date:  2010 Nov-Dec       Impact factor: 1.930

Review 4.  Cardiac outflow tract anomalies.

Authors:  Zachary Neeb; Jacquelyn D Lajiness; Esther Bolanis; Simon J Conway
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013-02-19       Impact factor: 5.814

5.  Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation.

Authors:  Bingruo Wu; Yidong Wang; Wendy Lui; Melissa Langworthy; Kevin L Tompkins; Antonis K Hatzopoulos; H Scott Baldwin; Bin Zhou
Journal:  Circ Res       Date:  2011-05-19       Impact factor: 17.367

Review 6.  Mechanisms of tissue fusion during development.

Authors:  Heather J Ray; Lee Niswander
Journal:  Development       Date:  2012-05       Impact factor: 6.868

7.  The arterial orifice level in the early human embryo.

Authors:  M M Bartelings; A C Gittenberger-de Groot
Journal:  Anat Embryol (Berl)       Date:  1988

Review 8.  Nfatc1 directs the endocardial progenitor cells to make heart valve primordium.

Authors:  Bingruo Wu; H Scott Baldwin; Bin Zhou
Journal:  Trends Cardiovasc Med       Date:  2013-05-10       Impact factor: 6.677

9.  Normal and abnormal development of the intrapericardial arterial trunks in humans and mice.

Authors:  Robert H Anderson; Bill Chaudhry; Timothy J Mohun; Simon D Bamforth; Darren Hoyland; Helen M Phillips; Sandra Webb; Antoon F M Moorman; Nigel A Brown; Deborah J Henderson
Journal:  Cardiovasc Res       Date:  2012-04-12       Impact factor: 10.787

10.  Three-dimensional and molecular analysis of the arterial pole of the developing human heart.

Authors:  Aleksander Sizarov; Wouter H Lamers; Timothy J Mohun; Nigel A Brown; Robert H Anderson; Antoon F M Moorman
Journal:  J Anat       Date:  2012-02-01       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.